nodes	percent_of_prediction	percent_of_DWPC	metapath
Octreotide—MPO—Propylthiouracil—Graves' disease	0.843	1	CbGbCtD
Octreotide—SSTR4—GPCRs, Class A Rhodopsin-like—GPR174—Graves' disease	0.00695	0.0816	CbGpPWpGaD
Octreotide—SSTR5—pituitary gland—Graves' disease	0.00588	0.209	CbGeAlD
Octreotide—SSTR3—pituitary gland—Graves' disease	0.00564	0.2	CbGeAlD
Octreotide—SSTR3—GPCRs, Class A Rhodopsin-like—GPR174—Graves' disease	0.00526	0.0618	CbGpPWpGaD
Octreotide—SSTR2—eye—Graves' disease	0.00511	0.181	CbGeAlD
Octreotide—SSTR1—GPCRs, Class A Rhodopsin-like—GPR174—Graves' disease	0.00505	0.0593	CbGpPWpGaD
Octreotide—SSTR5—GPCRs, Class A Rhodopsin-like—GPR174—Graves' disease	0.00448	0.0526	CbGpPWpGaD
Octreotide—SSTR1—pituitary gland—Graves' disease	0.00446	0.158	CbGeAlD
Octreotide—SSTR2—GPCRs, Class A Rhodopsin-like—GPR174—Graves' disease	0.00413	0.0485	CbGpPWpGaD
Octreotide—SSTR4—Peptide GPCRs—TSHR—Graves' disease	0.00401	0.0471	CbGpPWpGaD
Octreotide—SSTR2—pituitary gland—Graves' disease	0.00379	0.135	CbGeAlD
Octreotide—Neuritis—Methimazole—Graves' disease	0.00349	0.0805	CcSEcCtD
Octreotide—SSTR3—Peptide GPCRs—TSHR—Graves' disease	0.00304	0.0357	CbGpPWpGaD
Octreotide—Neuritis—Propylthiouracil—Graves' disease	0.00297	0.0685	CcSEcCtD
Octreotide—SSTR1—Peptide GPCRs—TSHR—Graves' disease	0.00291	0.0342	CbGpPWpGaD
Octreotide—SSTR5—Peptide GPCRs—TSHR—Graves' disease	0.00258	0.0303	CbGpPWpGaD
Octreotide—SSTR2—Peptide GPCRs—TSHR—Graves' disease	0.00238	0.028	CbGpPWpGaD
Octreotide—MPO—connective tissue—Graves' disease	0.00186	0.0661	CbGeAlD
Octreotide—Drowsiness—Methimazole—Graves' disease	0.00146	0.0336	CcSEcCtD
Octreotide—MPO—pituitary gland—Graves' disease	0.00144	0.0509	CbGeAlD
Octreotide—Neuropathy peripheral—Methimazole—Graves' disease	0.00143	0.033	CcSEcCtD
Octreotide—Jaundice—Methimazole—Graves' disease	0.00142	0.0328	CcSEcCtD
Octreotide—Hepatitis—Methimazole—Graves' disease	0.00131	0.0302	CcSEcCtD
Octreotide—SSTR4—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.00126	0.0149	CbGpPWpGaD
Octreotide—Drowsiness—Propylthiouracil—Graves' disease	0.00124	0.0286	CcSEcCtD
Octreotide—SSTR4—Peptide ligand-binding receptors—CXCL10—Graves' disease	0.00122	0.0143	CbGpPWpGaD
Octreotide—Neuropathy peripheral—Propylthiouracil—Graves' disease	0.00122	0.028	CcSEcCtD
Octreotide—Jaundice—Propylthiouracil—Graves' disease	0.00121	0.0279	CcSEcCtD
Octreotide—Alopecia—Methimazole—Graves' disease	0.00116	0.0267	CcSEcCtD
Octreotide—Hepatitis—Propylthiouracil—Graves' disease	0.00111	0.0257	CcSEcCtD
Octreotide—SSTR4—G alpha (i) signalling events—CXCL10—Graves' disease	0.00103	0.0121	CbGpPWpGaD
Octreotide—Vertigo—Methimazole—Graves' disease	0.00102	0.0236	CcSEcCtD
Octreotide—Alopecia—Propylthiouracil—Graves' disease	0.000984	0.0227	CcSEcCtD
Octreotide—Arthralgia—Methimazole—Graves' disease	0.00097	0.0224	CcSEcCtD
Octreotide—Myalgia—Methimazole—Graves' disease	0.00097	0.0224	CcSEcCtD
Octreotide—SSTR4—GPCR ligand binding—TSHR—Graves' disease	0.000963	0.0113	CbGpPWpGaD
Octreotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000959	0.0113	CbGpPWpGaD
Octreotide—Oedema—Methimazole—Graves' disease	0.00093	0.0215	CcSEcCtD
Octreotide—SSTR3—Peptide ligand-binding receptors—CXCL10—Graves' disease	0.000924	0.0108	CbGpPWpGaD
Octreotide—MPO—Vitamin B12 Metabolism—ICAM1—Graves' disease	0.000921	0.0108	CbGpPWpGaD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000919	0.0108	CbGpPWpGaD
Octreotide—Thrombocytopenia—Methimazole—Graves' disease	0.000911	0.021	CcSEcCtD
Octreotide—MPO—IL23-mediated signaling events—IFNG—Graves' disease	0.000906	0.0106	CbGpPWpGaD
Octreotide—SSTR1—Peptide ligand-binding receptors—CXCL10—Graves' disease	0.000885	0.0104	CbGpPWpGaD
Octreotide—MPO—IL23-mediated signaling events—CD4—Graves' disease	0.000875	0.0103	CbGpPWpGaD
Octreotide—Vertigo—Propylthiouracil—Graves' disease	0.000871	0.0201	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Methimazole—Graves' disease	0.000847	0.0195	CcSEcCtD
Octreotide—Paraesthesia—Methimazole—Graves' disease	0.000835	0.0193	CcSEcCtD
Octreotide—Somnolence—Methimazole—Graves' disease	0.000827	0.0191	CcSEcCtD
Octreotide—Arthralgia—Propylthiouracil—Graves' disease	0.000825	0.019	CcSEcCtD
Octreotide—Myalgia—Propylthiouracil—Graves' disease	0.000825	0.019	CcSEcCtD
Octreotide—Dyspepsia—Methimazole—Graves' disease	0.000819	0.0189	CcSEcCtD
Octreotide—SSTR4—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000817	0.0096	CbGpPWpGaD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000815	0.00957	CbGpPWpGaD
Octreotide—MPO—IL23-mediated signaling events—IL1B—Graves' disease	0.000808	0.00949	CbGpPWpGaD
Octreotide—Oedema—Propylthiouracil—Graves' disease	0.000791	0.0182	CcSEcCtD
Octreotide—SSTR5—Peptide ligand-binding receptors—CXCL10—Graves' disease	0.000785	0.00922	CbGpPWpGaD
Octreotide—SSTR3—G alpha (i) signalling events—CXCL10—Graves' disease	0.000779	0.00915	CbGpPWpGaD
Octreotide—Thrombocytopenia—Propylthiouracil—Graves' disease	0.000774	0.0179	CcSEcCtD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000752	0.00883	CbGpPWpGaD
Octreotide—MPO—Folate Metabolism—ICAM1—Graves' disease	0.000749	0.0088	CbGpPWpGaD
Octreotide—SSTR1—G alpha (i) signalling events—CXCL10—Graves' disease	0.000747	0.00877	CbGpPWpGaD
Octreotide—Urticaria—Methimazole—Graves' disease	0.000739	0.017	CcSEcCtD
Octreotide—Body temperature increased—Methimazole—Graves' disease	0.000735	0.017	CcSEcCtD
Octreotide—SSTR3—GPCR ligand binding—TSHR—Graves' disease	0.00073	0.00857	CbGpPWpGaD
Octreotide—SSTR2—Peptide ligand-binding receptors—CXCL10—Graves' disease	0.000725	0.00851	CbGpPWpGaD
Octreotide—Musculoskeletal discomfort—Propylthiouracil—Graves' disease	0.00072	0.0166	CcSEcCtD
Octreotide—Paraesthesia—Propylthiouracil—Graves' disease	0.00071	0.0164	CcSEcCtD
Octreotide—Somnolence—Propylthiouracil—Graves' disease	0.000703	0.0162	CcSEcCtD
Octreotide—MPO—Vitamin B12 Metabolism—IFNG—Graves' disease	0.000701	0.00823	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—TSHR—Graves' disease	0.0007	0.00822	CbGpPWpGaD
Octreotide—Dyspepsia—Propylthiouracil—Graves' disease	0.000696	0.0161	CcSEcCtD
Octreotide—SSTR5—G alpha (i) signalling events—CXCL10—Graves' disease	0.000662	0.00778	CbGpPWpGaD
Octreotide—Pruritus—Methimazole—Graves' disease	0.000658	0.0152	CcSEcCtD
Octreotide—Urticaria—Propylthiouracil—Graves' disease	0.000628	0.0145	CcSEcCtD
Octreotide—Body temperature increased—Propylthiouracil—Graves' disease	0.000625	0.0144	CcSEcCtD
Octreotide—MPO—Vitamin B12 Metabolism—IL1B—Graves' disease	0.000625	0.00734	CbGpPWpGaD
Octreotide—SSTR4—GPCR ligand binding—CXCL10—Graves' disease	0.000622	0.00731	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—TSHR—Graves' disease	0.000621	0.00729	CbGpPWpGaD
Octreotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000619	0.00727	CbGpPWpGaD
Octreotide—SSTR2—G alpha (i) signalling events—CXCL10—Graves' disease	0.000611	0.00718	CbGpPWpGaD
Octreotide—MPO—Selenium Micronutrient Network—ICAM1—Graves' disease	0.000595	0.00699	CbGpPWpGaD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000594	0.00697	CbGpPWpGaD
Octreotide—Vomiting—Methimazole—Graves' disease	0.000591	0.0136	CcSEcCtD
Octreotide—Rash—Methimazole—Graves' disease	0.000586	0.0135	CcSEcCtD
Octreotide—MPO—IL23-mediated signaling events—TNF—Graves' disease	0.000586	0.00688	CbGpPWpGaD
Octreotide—Dermatitis—Methimazole—Graves' disease	0.000586	0.0135	CcSEcCtD
Octreotide—Headache—Methimazole—Graves' disease	0.000583	0.0134	CcSEcCtD
Octreotide—SSTR2—GPCR ligand binding—TSHR—Graves' disease	0.000573	0.00673	CbGpPWpGaD
Octreotide—MPO—Folate Metabolism—IFNG—Graves' disease	0.00057	0.00669	CbGpPWpGaD
Octreotide—Pruritus—Propylthiouracil—Graves' disease	0.000559	0.0129	CcSEcCtD
Octreotide—Nausea—Methimazole—Graves' disease	0.000552	0.0127	CcSEcCtD
Octreotide—SSTR4—GPCR downstream signaling—TSHR—Graves' disease	0.000544	0.00639	CbGpPWpGaD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000527	0.00619	CbGpPWpGaD
Octreotide—MPO—Folate Metabolism—IL1B—Graves' disease	0.000508	0.00597	CbGpPWpGaD
Octreotide—Vomiting—Propylthiouracil—Graves' disease	0.000503	0.0116	CcSEcCtD
Octreotide—Rash—Propylthiouracil—Graves' disease	0.000499	0.0115	CcSEcCtD
Octreotide—Dermatitis—Propylthiouracil—Graves' disease	0.000498	0.0115	CcSEcCtD
Octreotide—Headache—Propylthiouracil—Graves' disease	0.000495	0.0114	CcSEcCtD
Octreotide—SSTR4—Signaling by GPCR—TSHR—Graves' disease	0.000494	0.00581	CbGpPWpGaD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000486	0.00571	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—CXCL10—Graves' disease	0.000472	0.00554	CbGpPWpGaD
Octreotide—Nausea—Propylthiouracil—Graves' disease	0.00047	0.0108	CcSEcCtD
Octreotide—SSTR1—SIDS Susceptibility Pathways—IL1B—Graves' disease	0.000466	0.00548	CbGpPWpGaD
Octreotide—MPO—C-MYB transcription factor network—CD4—Graves' disease	0.000454	0.00533	CbGpPWpGaD
Octreotide—MPO—Vitamin B12 Metabolism—TNF—Graves' disease	0.000453	0.00533	CbGpPWpGaD
Octreotide—MPO—Selenium Micronutrient Network—IFNG—Graves' disease	0.000453	0.00532	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—CXCL10—Graves' disease	0.000452	0.00531	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—TSHR—Graves' disease	0.000413	0.00484	CbGpPWpGaD
Octreotide—MPO—Selenium Micronutrient Network—IL1B—Graves' disease	0.000404	0.00474	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—CXCL10—Graves' disease	0.000401	0.00471	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—TSHR—Graves' disease	0.000396	0.00464	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—IL1B—Graves' disease	0.000382	0.00448	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—TSHR—Graves' disease	0.000375	0.0044	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—CXCL10—Graves' disease	0.00037	0.00435	CbGpPWpGaD
Octreotide—MPO—Folate Metabolism—TNF—Graves' disease	0.000369	0.00433	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—TSHR—Graves' disease	0.000359	0.00422	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—CXCL10—Graves' disease	0.000352	0.00413	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—TSHR—Graves' disease	0.000351	0.00412	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—TNF—Graves' disease	0.000338	0.00397	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—TSHR—Graves' disease	0.000324	0.0038	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—CXCL10—Graves' disease	0.000319	0.00375	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—TSHR—Graves' disease	0.000319	0.00374	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—TSHR—Graves' disease	0.000294	0.00345	CbGpPWpGaD
Octreotide—MPO—Selenium Micronutrient Network—TNF—Graves' disease	0.000293	0.00344	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—TSHR—Graves' disease	0.000292	0.00343	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—TNF—Graves' disease	0.000277	0.00325	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—IL2RA—Graves' disease	0.000269	0.00316	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—CXCL10—Graves' disease	0.000267	0.00313	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—CXCL10—Graves' disease	0.000256	0.003	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—IL2RA—Graves' disease	0.000244	0.00287	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—CXCL10—Graves' disease	0.000242	0.00284	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—CXCL10—Graves' disease	0.000232	0.00273	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—CXCL10—Graves' disease	0.000227	0.00266	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TSHR—Graves' disease	0.000221	0.0026	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TSHR—Graves' disease	0.000212	0.00249	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—CXCL10—Graves' disease	0.000209	0.00246	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—CXCL10—Graves' disease	0.000206	0.00242	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—IL2RA—Graves' disease	0.000204	0.00239	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—IL2RA—Graves' disease	0.000195	0.00229	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—CXCL10—Graves' disease	0.00019	0.00223	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CXCL10—Graves' disease	0.000189	0.00222	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TSHR—Graves' disease	0.000188	0.00221	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—IL2RA—Graves' disease	0.000185	0.00217	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—IL2RA—Graves' disease	0.000177	0.00208	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TSHR—Graves' disease	0.000174	0.00204	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—IL2RA—Graves' disease	0.000173	0.00203	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—IL2RA—Graves' disease	0.00016	0.00188	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—IL2RA—Graves' disease	0.000157	0.00185	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—IL2RA—Graves' disease	0.000145	0.00171	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—IL2RA—Graves' disease	0.000144	0.00169	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CXCL10—Graves' disease	0.000143	0.00168	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CXCL10—Graves' disease	0.000137	0.00161	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CXCL10—Graves' disease	0.000122	0.00143	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CXCL10—Graves' disease	0.000112	0.00132	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IL2RA—Graves' disease	0.000109	0.00128	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IL2RA—Graves' disease	0.000105	0.00123	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IL2RA—Graves' disease	9.29e-05	0.00109	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IL2RA—Graves' disease	8.58e-05	0.00101	CbGpPWpGaD
